These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37532831)

  • 1. Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
    Liu JY; Yu ZL; Fu QY; Zhang LZ; Li JB; Wu M; Liu B; Chen G
    Br J Cancer; 2023 Oct; 129(6):925-934. PubMed ID: 37532831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy.
    Xiao BL; Wang XL; Xia HF; Zhang LZ; Wang KM; Chen ZK; Zhong YH; Jiang HG; Zhou FX; Wang W; Chen GL; Chen G
    Cancer Immunol Res; 2023 Feb; 11(2):228-240. PubMed ID: 36484721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
    Li M; Soder R; Abhyankar S; Abdelhakim H; Braun MW; Trinidad CV; Pathak HB; Pessetto Z; Deighan C; Ganguly S; Dawn B; McGuirk J; Dunavin N; Godwin AK
    J Extracell Vesicles; 2021 Feb; 10(4):e12067. PubMed ID: 33598108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1/CD80
    Zhang LZ; Yang JG; Chen GL; Xie QH; Fu QY; Xia HF; Li YC; Huang J; Li Y; Wu M; Liu HM; Wang FB; Yi KZ; Jiang HG; Zhou FX; Wang W; Yu ZL; Zhang W; Zhong YH; Bian Z; Yang HY; Liu B; Chen G
    Nat Commun; 2024 May; 15(1):3884. PubMed ID: 38719909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer.
    Jablonska J; Rist M; Spyra I; Tengler L; Domnich M; Kansy B; Giebel B; Thakur BK; Rotter N; Lang S; Ludwig S
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer.
    Rubenich DS; Domagalski JL; Gentil GFS; Eichberger J; Fiedler M; Weber F; Federlin M; Poeck H; Reichert TE; Ettl T; Bauer RJ; Braganhol E; Schulz D
    J Extracell Vesicles; 2024 Jul; 13(7):e12480. PubMed ID: 38978304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
    Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
    Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.
    Netzer C; von Arps-Aubert V; Mačinković I; von der Grün J; Küffer S; Ströbel P; von Knethen A; Weigert A; Beutner D
    Front Immunol; 2023; 14():1240394. PubMed ID: 38322012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-Assisted Traceless Isolation of PD-L1-Positive Small Extracellular Vesicles for Dissecting Their Subpopulation Signature and Function.
    Xu R; Yu ZL; Liu XC; Xie QH; Wu M; Chen G
    Anal Chem; 2023 Jan; 95(2):1016-1026. PubMed ID: 36534080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 Carried on Small Extracellular Vesicles Leads to OSCC Metastasis.
    Zhang LZ; Yang JG; Xia HF; Huang J; Liu HM; Wu M; Liu B; Wang WM; Chen G
    J Dent Res; 2023 Jul; 102(7):795-805. PubMed ID: 37246810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer.
    Zhu G; Wang L; Meng W; Lu S; Cao B; Liang X; He C; Hao Y; Du X; Wang X; Li L; Li L
    Theranostics; 2021; 11(19):9198-9216. PubMed ID: 34646366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways.
    Pucci M; Raimondo S; Urzì O; Moschetti M; Di Bella MA; Conigliaro A; Caccamo N; La Manna MP; Fontana S; Alessandro R
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the LMP1-ALIX axis in EBV
    He F; Gong Y; Tao G; Zhang J; Wu Q; Tan Y; Cheng Y; Wang C; Yang J; Han L; Wang Z; Gao Y; He J; Bai R; Sun P; Yu X; Zhou Y; Xie C
    Cancer Commun (Lond); 2024 Dec; 44(12):1391-1413. PubMed ID: 39402748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
    Jung D; Shin S; Kang SM; Jung I; Ryu S; Noh S; Choi SJ; Jeong J; Lee BY; Kim KS; Kim CS; Yoon JH; Lee CH; Bucher F; Kim YN; Im SH; Song BJ; Yea K; Baek MC
    J Extracell Vesicles; 2022 Dec; 11(12):e12287. PubMed ID: 36447429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
    Ou Q; Dou X; Tang J; Wu P; Pan D
    Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy.
    Chen ZK; Zheng S; Long Y; Wang KM; Xiao BL; Li JB; Zhang W; Song H; Chen G
    Mol Ther; 2024 Oct; 32(10):3580-3596. PubMed ID: 39217416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage.
    Wei F; Fang R; Lyu K; Liao J; Long Y; Yang J; Wen W; Sun W
    Oral Oncol; 2023 Oct; 145():106532. PubMed ID: 37499326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages.
    Xu D; Chen WQ; Liang MX; Chen X; Liu Z; Fei YJ; Shao XY; Wu Y; Zhang W; Tang JH
    Cancer Cell Int; 2023 Jul; 23(1):137. PubMed ID: 37452413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment.
    Lu T; Zhang Z; Zhang J; Pan X; Zhu X; Wang X; Li Z; Ruan M; Li H; Chen W; Yan M
    J Extracell Vesicles; 2022 May; 11(5):e12218. PubMed ID: 35524455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.